|
HS Code |
439235 |
| Chemical Name | Scopolamine N-Oxide Hydrobromide Monohydrate |
| Cas Number | 7598-40-5 |
| Molecular Formula | C17H22BrNO6·H2O |
| Molecular Weight | 452.28 g/mol |
| Appearance | White to off-white powder |
| Purity | Typically ≥98% |
| Storage Temperature | 2-8°C (refrigerated) |
| Solubility | Soluble in water |
| Synonyms | Hyoscine N-oxide hydrobromide monohydrate |
| Iupac Name | 6β,7β-Epoxy-3-α-tropanyl tropate N-oxide hydrobromide monohydrate |
| Hazard Statements | May be harmful if swallowed, causes eye and skin irritation |
| Stability | Stable under recommended storage conditions |
| Category | Tropane alkaloid derivative |
| Application | Pharmaceutical research; anticholinergic studies |
| Merck Index Number | 8502 |
As an accredited Scopolamine N-Oxide Hydrobromide Monohydrate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Applications of Scopolamine N-Oxide Hydrobromide Monohydrate in Industrial ManufacturingOur expertise in production and quality control has enabled precise integration of Scopolamine N-Oxide Hydrobromide Monohydrate into multiple industrial sectors. Each downstream application deploys this compound under stringent protocols, driven by regulatory and process requirements. Below, we detail its role across core markets, with specific compliance frameworks, formulation recommendations, process entries, and end-product categories. 1. Active Pharmaceutical Ingredient (API) Synthesis for Anticholinergic AgentsPharmaceutical manufacturers rely on Scopolamine N-Oxide Hydrobromide Monohydrate as a controlled intermediate for the synthesis and modification of anticholinergic active ingredients. Its N-oxide functional group enhances selectivity in quaternary ammonium pathways, supporting targeted molecular transformations. Regulatory oversight demands GMP documentation for every batch, with traceability from raw material intake through to final formulation. Teams adjust ratios depending on target drug strength and impurity profiles, while downstream processes must account for protection and deprotection steps under validated analytical controls. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Analytical Reagent and Reference Material ProductionQuality control laboratories in regulated industries use this compound in synthesizing certified analytical reference standards. Its defined N-oxide structure and precise hydrobromide salt form are essential for calibration procedures in HPLC, LC-MS, and related quantification methods. Laboratories demand batch-to-batch consistency and documentation to satisfy audits and traceability requirements during manufacturing, import, and analytical usage. All handling requires secure containment and ability to verify molecular integrity analytically. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Precursor for Plant-Derived Alkaloid Synthesis in Biotech R&DBiotechnology firms focused on secondary metabolite engineering use Scopolamine N-Oxide Hydrobromide Monohydrate as a model substrate for enzymatic and chemoenzymatic transformation studies. The compound’s stability and water solubility facilitate its deployment in substrate screening, pathway mapping, and flux analysis across microbial and plant systems. Process chemists and bioprocess engineers precisely monitor entry points into cultures or bioreactors under environmental and chain-of-custody controls. All activities adhere to biosafety, local statutory, and research-use-only guidelines, depending on contract project nature. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Preclinical Toxicology and Pharmacology Model CompoundSpecialty contract research organizations (CROs) integrate this material within controlled preclinical testing platforms to model the pharmacokinetics and metabolism of tropane derivatives. This usage demands exacting purity and documentation for regulatory filings under local animal and ethics legislation frameworks. Formulation teams prepare test article solutions at tightly monitored dosage levels, enabling precise data collection on distribution, metabolic conversion, or toxicity endpoints. Documentation packages link every step from compound reception to study archive. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Scopolamine N-Oxide Hydrobromide Monohydrate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Anyone interested in pharmacology or natural product chemistry comes across scopolamine and its derivatives sooner or later. These compounds have a long-standing place in medical research, used for decades to unlock new pathways in neuroscience, motion sickness treatment, and more. One product, Scopolamine N-Oxide Hydrobromide Monohydrate, stands out for those aiming to work with compounds that push the boundaries of both academic and clinical understanding.
From the many different molecules in the tropane alkaloid family, Scopolamine N-Oxide Hydrobromide Monohydrate carries unique features not always found in similar substances. The model most recognized in laboratories features the formula C17H24NO5 • HBr • H2O, and researchers usually handle it as a fine, crystalline powder. The N-oxide functional group and the hydrobromide salt both shape the substance’s properties, most notably by enhancing its solubility in water, a practical benefit for anyone preparing dosing solutions or formulating for in vivo work.
In my own experience, handling more traditional scopolamine hydrobromide compared with the N-oxide derivative reveals some subtle, and sometimes not-so-subtle, differences. You get a slightly different stability profile due to the presence of the N-oxide moiety. Still, your workflow as a chemist does not shift dramatically—what changes is the reactivity and biological profile. That’s where the rubber meets the road for project outcomes.
Researchers in neuroscience often seek new angles to block or modulate cholinergic transmission. The emphasis on the central nervous system makes scopolamine-based derivatives like this one a strong candidate for studies into memory impairment, dementia modeling, or cholinergic system mapping. Traditional scopolamine has a long track record in these areas, yet the N-oxide opens the door to nuanced pharmacokinetic properties and can sometimes yield results that are less confounded by off-target muscarinic effects.
On the analytical side, labs sometimes use Scopolamine N-Oxide Hydrobromide Monohydrate as an intermediate or reference standard. This is especially common for those developing or validating chromatographic methods for the quantification of natural alkaloids in plant extracts, which can present a surprisingly tricky challenge. Its extra oxygen atom gives it different polarity compared with non-oxidized compounds, so one can distinguish it more easily on a chromatogram.
I remember seeing a project stall because matrix interference made it nearly impossible to quantify scopolamine accurately using standard extraction and detection conditions. Swapping in the N-oxide as a standard for spike-and-recovery checks rolled past that roadblock, allowing calibration curves that tracked the actual analyte profile more faithfully.
One of the realities for lab professionals, especially in academic groups, is the lack of endless refrigeration or humidity-controlled space. Compared to some less stable alkaloid salts, Scopolamine N-Oxide Hydrobromide Monohydrate resists degradation better under typical storage. Once opened, the monohydrate form reduces clumping and avoids excessive moisture uptake from the air, a simple but important daily advantage for clean weighing and reconstitution.
The N-oxide’s improved water solubility versus parent scopolamine, particularly in buffered solutions, streamlines work for animal model studies. It can seem like an incremental benefit, but anyone who has suffered through endless sonication steps or filter clogs with less-friendly compounds will appreciate how much time this really saves. It also reduces error risk, a key point for reproducibility, especially when running small doses at low concentrations.
Scopolamine hydrobromide remains the clinical “workhorse,” mainly prescribed for motion sickness patches and certain emergency psychiatric interventions. In contrast, the N-oxide version rarely appears in pharmacy settings but is valued in research for its more specific applications. The N-oxide function can reduce off-target effects, which may be a lifesaver for teams pursuing cleaner animal behavior readouts or conducting in vitro studies where background noise confuses the results.
Take the antimuscarinic side effects: researchers working with standard scopolamine often report sedation or peripheral anticholinergic phenomena in mouse or rat models, sometimes muddying cognitive assessments. By contrast, the N-oxide’s profile helps reduce those confounds, letting teams dig into central effects without being overwhelmed by peripheral ones. In this sense, Scopolamine N-Oxide Hydrobromide Monohydrate gives experimental flexibility.
The chemistry community also values this product for synthetic transformations. Oxidizing scopolamine to the N-oxide proves tricky in-house and can introduce impurities. Procuring a reliable, ready-to-use N-oxide salt at verified high purity spares groups the time and safety hazards of making it themselves. For labs on a budget, this can be the difference between a promising project and one lost to complicated synthesis.
Work with tropane alkaloids always calls for care—these are potent anticholinergics, with health risks not to be dismissed. Unlike some more volatile organics, Scopolamine N-Oxide Hydrobromide Monohydrate’s stable crystalline form limits airborne exposure during handling. Researchers still use gloves and work in ventilated spaces, but this extra bit of safety margin matters in shared facilities or teaching labs.
On the environmental side, proper chemical waste protocols become more straightforward when dealing with well-characterized, stable molecules. It’s often easier to document and safely dispose of a defined alkaloid salt than a mixture of degradation products or intermediate byproducts. This is more than bureaucratic red tape—it protects everyone downstream and cuts future liability.
I’ve watched institutional safety committees become markedly less anxious about approving projects using well-documented, stable forms of high-potency compounds. Less drama translates into faster project starts and more straightforward compliance reports.
There’s a growing movement in pharmacological research to push beyond direct-acting compounds and investigate metabolites and transformation products. Scopolamine N-Oxide Hydrobromide Monohydrate represents one such direction. Some research groups are especially interested in its metabolic fate, both in vitro and in vivo. By tracing how the N-oxide transitions in biological systems, scientists can draw sharper maps of both biotransformation and excretion pathways.
This interest isn’t theoretical—the regulatory world shows rising scrutiny of drug metabolites. Compounds like Scopolamine N-Oxide Hydrobromide Monohydrate step in as valuable reference sources. Whether validating mass spectrometry methods or running metabolic fate studies, labs save enormous troubleshooting time and improve data integrity by having authentic standards with proven purity and documentation.
For those developing animal models of cognitive impairment, Scopolamine N-Oxide Hydrobromide Monohydrate opens up fresh approaches. Instead of falling back on the classic scopolamine-induced amnesia paradigm, researchers can explore how mild, reversible cholinergic blockade impacts test subjects differently with the N-oxide derivative. This nuanced modulation enables more sophisticated experimental designs, such as distinguishing between memory encoding and retrieval effects or dissecting peripheral from central pathways.
Behavioral pharmacology isn’t the only arena. Analytical chemistry teams draw on Scopolamine N-Oxide Hydrobromide Monohydrate to build more robust calibration protocols. Its chemical stability withstands extended sample prep times, and its aqueous solubility ensures cleaner, more precise injections into high-performance liquid chromatographs and mass spectrometers. These technical details add up to reliable data—critical for both peer-reviewed publication and contract research timelines.
For neuroscientists looking into cholinergic neurotransmission, the subtle switch from parent scopolamine to the N-oxide variant allows for targeted work. The choice often depends on the goal: if the aim centers around impairing cognition broadly, standard scopolamine does the job. For more specific studies where background contamination must be minimized, the N-oxide shines. Every project is different, but the flexibility to choose between closely related analogs, based on their known pharmacological quirks, makes for more rigorous and reproducible science.
Decades in the laboratory teach the same lesson over and over: the best science arises from well-characterized, reproducible materials. Scopolamine N-Oxide Hydrobromide Monohydrate purchased from a reputable supplier typically comes with lot-specific certificates of analysis and up-to-date safety information, critical in an era where journals and funding agencies expect detailed sourcing in every methods section.
Beyond scientific integrity, having access to authenticated compounds streamlines regulatory submissions and research reviews. In one of my own multi-center projects, inconsistent results between labs often traced back to differences in reagent batches or preparation. Agreeing on a single, characterized standard for Scopolamine N-Oxide Hydrobromide Monohydrate delivered quantifiable improvements in both data quality and inter-laboratory trust.
Tools like Scopolamine N-Oxide Hydrobromide Monohydrate expand the toolkit for academic and industry researchers. There’s huge value in being able to interrogate biological systems with precision. As more groups emphasize transparency and reproducibility, the use of well-documented, functionally differentiated derivatives makes ground-breaking discoveries possible while safeguarding participant safety and study credibility.
It’s not just about picking a new compound for the sake of novelty. The unique features of the N-oxide—water solubility, altered metabolism, and reduced peripheral antimuscarinic effect—open new applications science can’t easily reach with older reagents. Combined with robust supplier documentation and easier handling, Scopolamine N-Oxide Hydrobromide Monohydrate addresses both daily research needs and big-picture scientific aims.
Anyone serious about pushing tropane alkaloid science forward should look beyond the usual stock compounds. Investing in quality, differentiated reagents has paid dividends on my own bench and across the many collaborative projects I’ve witnessed throughout my career. As investigations deepen into cognition, neurodegeneration, or analytical control, nuanced tools like this one drive reliable answers from tomorrow’s experiments.
Research these days rarely unfolds in isolation. Collaborative teams need shared expectations—clear sourcing, batch traceability, and certainty about the materials underpinning their studies. Scopolamine N-Oxide Hydrobromide Monohydrate’s rise reflects more than just a tweak in chemistry; it answers a practical demand for customizable, verifiable standards that help connect labs from different regions or even different nations.
My experience with global teams underscores this. Shipping or importing alkaloids presents hurdles, but when a compound’s pedigree and purity are transparently documented, customs delays and regulatory headaches shrink. This reliability doesn’t cure every challenge, but it eliminates one common barrier between scientific partners working continents apart.
The pace of discovery in neuropharmacology and plant chemistry shows no sign of slowing down. Every year, new diagnostic tools and treatment ideas trace their roots back to careful studies using compounds just like Scopolamine N-Oxide Hydrobromide Monohydrate. Their role may not make headlines, but for the professionals at the lab bench, the impact is clear: smarter experimental setup, safer handling, and cleaner, more reliable results.
Stakeholders—from graduate students starting their first animal study to seasoned analytical chemists writing regulatory submissions—benefit from access to specialty derivatives with clear advantages over general-use compounds. My own career has taught me that small improvements in bench chemistry often open the door to major breakthroughs, provided the right tools are available and well understood.
Scopolamine N-Oxide Hydrobromide Monohydrate represents a convergence of practical handling, scientific rigor, and innovative possibility. In the landscape of alkaloid research and application, its place is well earned by delivering on the real working needs of the modern laboratory. For any lab looking to blend safety, precision, and progress, this compound deserves a close look and a thoughtful place in the arsenal.